Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
35532 | 95 | 27.4 | 42% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
410 | 3 | HEAT SHOCK PROTEIN//HSP90//HSP70 | 29410 |
990 | 2 | LENS//CATARACT//ALPHA CRYSTALLIN | 10510 |
35532 | 1 | BENDAZAC//BOVINE EARS//ANTI DENATURANT AGENTS | 95 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BENDAZAC | authKW | 1446422 | 6% | 75% | 6 |
2 | BOVINE EARS | authKW | 642855 | 2% | 100% | 2 |
3 | ANTI DENATURANT AGENTS | authKW | 321428 | 1% | 100% | 1 |
4 | BENDALINE | authKW | 321428 | 1% | 100% | 1 |
5 | BENDAZAC LYSINE ANALOGUES | authKW | 321428 | 1% | 100% | 1 |
6 | BENDAZAC LYSINE SALT | authKW | 321428 | 1% | 100% | 1 |
7 | BYTTNERIA HERBACEA | authKW | 321428 | 1% | 100% | 1 |
8 | FENTON CIER REACTION | authKW | 321428 | 1% | 100% | 1 |
9 | FREE AMINO ACIDS AND DIABETES MELLITUS | authKW | 321428 | 1% | 100% | 1 |
10 | FURO2 3 CPYRAZOLE 5 CARBOXAMIDE | authKW | 321428 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 409 | 39% | 0% | 37 |
2 | Ophthalmology | 354 | 17% | 0% | 16 |
3 | Biophysics | 29 | 7% | 0% | 7 |
4 | Biochemistry & Molecular Biology | 18 | 16% | 0% | 15 |
5 | Medicine, General & Internal | 15 | 7% | 0% | 7 |
6 | Chemistry, Multidisciplinary | 13 | 11% | 0% | 10 |
7 | Chemistry, Medicinal | 13 | 4% | 0% | 4 |
8 | Toxicology | 13 | 4% | 0% | 4 |
9 | Medical Laboratory Technology | 12 | 2% | 0% | 2 |
10 | Medicine, Research & Experimental | 11 | 5% | 0% | 5 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | OBSTET SURG UNIT | 321428 | 1% | 100% | 1 |
2 | S S | 64284 | 1% | 20% | 1 |
3 | TOXICOGEN INFORMAT PROJECT | 24723 | 1% | 8% | 1 |
4 | DIPARTIMENTO SCI OFTALMOL | 15304 | 1% | 5% | 1 |
5 | PHARMACOL NAT SUBST GEN PHYSIOL | 15122 | 2% | 2% | 2 |
6 | SEZ B | 13973 | 1% | 4% | 1 |
7 | EXPT CLIN MED PHARMACOL | 10043 | 1% | 3% | 1 |
8 | PHARMACOL PHARMACOGNOSY | 9886 | 2% | 2% | 2 |
9 | DIPARTIMENTO SCI INVECCHIAMENTO | 9182 | 1% | 3% | 1 |
10 | VIS FDN | 8567 | 2% | 1% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | REVISTA BRASILEIRA DE MEDICINA | 13116 | 2% | 2% | 2 |
2 | ACTA THERAPEUTICA | 5180 | 2% | 1% | 2 |
3 | AGENTS AND ACTIONS | 3602 | 6% | 0% | 6 |
4 | PHARMACOLOGICAL RESEARCH COMMUNICATIONS | 3166 | 3% | 0% | 3 |
5 | EUROPEAN JOURNAL OF RHEUMATOLOGY AND INFLAMMATION | 2007 | 1% | 1% | 1 |
6 | INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS | 2005 | 4% | 0% | 4 |
7 | PRENSA MEDICA ARGENTINA | 1814 | 1% | 1% | 1 |
8 | BULLETIN OF THE HOSPITAL FOR JOINT DISEASES ORTHOPAEDIC INSTITUTE | 1708 | 1% | 1% | 1 |
9 | ENZYME | 1701 | 2% | 0% | 2 |
10 | INTERNATIONAL JOURNAL OF TISSUE REACTIONS-EXPERIMENTAL AND CLINICAL ASPECTS | 1410 | 2% | 0% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BENDAZAC | 1446422 | 6% | 75% | 6 | Search BENDAZAC | Search BENDAZAC |
2 | BOVINE EARS | 642855 | 2% | 100% | 2 | Search BOVINE+EARS | Search BOVINE+EARS |
3 | ANTI DENATURANT AGENTS | 321428 | 1% | 100% | 1 | Search ANTI+DENATURANT+AGENTS | Search ANTI+DENATURANT+AGENTS |
4 | BENDALINE | 321428 | 1% | 100% | 1 | Search BENDALINE | Search BENDALINE |
5 | BENDAZAC LYSINE ANALOGUES | 321428 | 1% | 100% | 1 | Search BENDAZAC+LYSINE+ANALOGUES | Search BENDAZAC+LYSINE+ANALOGUES |
6 | BENDAZAC LYSINE SALT | 321428 | 1% | 100% | 1 | Search BENDAZAC+LYSINE+SALT | Search BENDAZAC+LYSINE+SALT |
7 | BYTTNERIA HERBACEA | 321428 | 1% | 100% | 1 | Search BYTTNERIA+HERBACEA | Search BYTTNERIA+HERBACEA |
8 | FENTON CIER REACTION | 321428 | 1% | 100% | 1 | Search FENTON+CIER+REACTION | Search FENTON+CIER+REACTION |
9 | FREE AMINO ACIDS AND DIABETES MELLITUS | 321428 | 1% | 100% | 1 | Search FREE+AMINO+ACIDS+AND+DIABETES+MELLITUS | Search FREE+AMINO+ACIDS+AND+DIABETES+MELLITUS |
10 | FURO2 3 CPYRAZOLE 5 CARBOXAMIDE | 321428 | 1% | 100% | 1 | Search FURO2+3+CPYRAZOLE+5+CARBOXAMIDE | Search FURO2+3+CPYRAZOLE+5+CARBOXAMIDE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SHEN, H , GOU, SH , SHEN, JP , ZHU, YQ , ZHANG, YD , CHEN, XT , (2010) SYNTHESIS AND BIOLOGICAL EVALUATIONS OF NOVEL BENDAZAC LYSINE ANALOGUES AS POTENT ANTICATARACT AGENTS.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. VOL. 20. ISSUE 7. P. 2115 -2118 | 12 | 50% | 4 |
2 | BALFOUR, JA , CLISSOLD, SP , (1990) BENDAZAC LYSINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL IN THE MANAGEMENT OF CATARACTS.DRUGS. VOL. 39. ISSUE 4. P. 575-596 | 16 | 64% | 27 |
3 | ZHU, PX , YANG, WF , HONG, LY , CHENG, QY , LUO, L , HE, JJ , CHEN, JJ , (2015) CHARACTERIZATION OF A NOVEL PROCESS-RELATED IMPURITY IN COMMERCIAL BENDAZAC LYSINE EYE DROPS BY LC-ESI-QTOF/MS/MS AND NMR.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 107. ISSUE . P. 437 -443 | 5 | 50% | 1 |
4 | JEZ, JM , VANDERKOOI, JM , LATIES, AM , (1996) SPECTROSCOPIC CHARACTERIZATION OF BENDAZAC AND BENZYDAMINE: POSSIBLE PHOTOCHEMICAL MODES OF ACTION.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. VOL. 221. ISSUE 2. P. 266-270 | 7 | 58% | 2 |
5 | SASO, L , SILVESTRINI, B , (2001) ANTIDENATURANT DRUGS FOR CATARACT AND OTHER CONDENSATION DISEASES.MEDICAL HYPOTHESES. VOL. 56. ISSUE 1. P. 114 -120 | 18 | 18% | 7 |
6 | ROVEI, V , ESCOURROU, J , CAMPISTRON, G , EGO, D , THIOLA, A , RIBET, A , HOUIN, G , (1988) THE PHARMACOKINETICS OF BENDAZAC-LYSINE AND 5-HYDROXYBENDAZAC, ITS MAIN METABOLITE, IN PATIENTS WITH HEPATIC CIRRHOSIS.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 35. ISSUE 4. P. 391-396 | 4 | 80% | 1 |
7 | BARCELLONA, PS , CAMPANA, A , CARANTI, S , DONOFRIO, E , SILVESTRINI, B , (1991) PRETREATMENT WITH BENDAZAC ATTENUATES RETINAL DAMAGE INDUCED BY INTENSE LIGHT IN RATS.PHARMACOLOGICAL RESEARCH. VOL. 24. ISSUE 1. P. 105-112 | 4 | 67% | 1 |
8 | CHEN, XX , ZHANG, YD , SHEN, JP , PU, J , YAN, HY , ZHU, YQ , QIU, JJ , (1997) PHARMACOKINETICS OF BENDAZAC LYSINE IN 10 CHINESE YOUNG MEN.ACTA PHARMACOLOGICA SINICA. VOL. 18. ISSUE 2. P. 109-111 | 2 | 100% | 1 |
9 | HOCKWIN, O , LASER, H , DEGREGORIO, M , CARRIERI, MP , (1989) BENDAZAC LYSINE IN SELECTED TYPES OF HUMAN SENILE CATARACT - A LONG-TERM DOUBLE-MASKED PLACEBO-CONTROLLED CLINICAL-TRIAL WITH MULTILINEAR DENSITOMETRIC IMAGE-ANALYSIS OF SCHEIMPFLUG PHOTOGRAPHS.OPHTHALMIC RESEARCH. VOL. 21. ISSUE 3. P. 141-154 | 5 | 56% | 8 |
10 | SRINIVASAN, V , RAJESH, M , SULOCHANA, KN , INDRA, C , RAMAKRISHNAN, S , (2005) AMINO ACIDS DIFFERENTIALLY REGULATE INSULIN RECEPTOR TYROSINE KINASE AND PHOSPHATIDYL INOSITOL-3-OH-KINASE ACTIVITIES IN HUMAN MONOCYTES EXPOSED TO HIGH GLUCOSE CONCENTRATION.INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS. VOL. 42. ISSUE 1. P. 13 -18 | 6 | 23% | 1 |
Classes with closest relation at Level 1 |